Why the study?
Does biomarker-guided shorter aspirin discontinuation (4-5 days) prevent perioperative bleeding and thromboembolic complications compared to standard 10-day discontinuation in patients undergoing elective noncardiac surgery?
Does biomarker-guided shorter aspirin discontinuation (4-5 days) prevent perioperative bleeding and thromboembolic complications compared to standard 10-day discontinuation in patients undergoing elective noncardiac surgery?
Reducing aspirin cessation time from 7-10 days to 4-5 days before elective noncardiac surgery appears safe for secondary prevention patients without increasing perioperative complications.
No takes yet. Share an insight, caveat, or question.
May support shorter aspirin cessation before noncardiac surgery; hypothesis-generating and should not yet change practice.
Gülpınar et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: